ClassID:

93629

C07C323/67 - CPC Classification

Classification description:

Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton

Recent Application in this class:
#1
20230390354
2023-12-07

Cytotoxic and anti-mitotic compounds, and methods of using the same

#2
20220112160
2022-04-14

Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interaction

#3
20210317074
2021-10-14

HISTONE ACETYLTRANSFERASE ACTIVATORS AND USES THEREOF

#4
20210053915
2021-02-25

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#5
20200115325
2020-04-16

Histone acetyltransferase activators and uses thereof

#6
20200109110
2020-04-09

Sulfur derivatives as chemokine receptor modulators

#7
20200087253
2020-03-19

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#8
20190359566
2019-11-28

Pre-assembled, protected, chemically stable, chemoselective linkers

#9
20190269785
2019-09-05

Cytotoxic and anti-mitotic compounds, and methods of using the same

#10
20190144380
2019-05-16

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#11
20180244610
2018-08-30

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#12
20170305847
2017-10-26

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#13
20170152221
2017-06-01

Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof

#14
20170022154
2017-01-26

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#15
20160151375
2016-06-02

Sulfide alkyl compounds for HBV treatment

#16
20160083342
2016-03-24

Sulfur derivatives as chemokine receptor modulators

#17
20160038606
2016-02-11

Cytotoxic and anti-mitotic compounds, and methods of using the same

#18
20160002156
2016-01-07

-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#19
20150266900
2015-09-24

Fluorinated benzenesulfonamides as inhibitors of carbonic anhydrase

#20
20140336396
2014-11-13

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#21
20140315954
2014-10-23

Cytotoxic and anti-mitotic compounds, and methods of using the same

#22
20140228302
2014-08-14

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPOXIC OR ISCHEMIC INJURY

#23
20130121919
2013-05-16

Histone acetyltransferase activators and uses thereof

#24
20130096105
2013-04-18

Arylsulfonamide based matrix metalloprotease inhibitors

#25
20120309796
2012-12-06

BENZOCYCLOHEPTENE ACETIC ACIDS

#26
20120258954
2012-10-11

Arylsulfonamide based matrix metalloprotease inhibitors

#27
20120157487
2012-06-21

Sulfur derivatives as chemokine receptor modulators

#28
20120157413
2012-06-21

Phosphorous derivatives as chemokine receptor modulators

#29
20120077976
2012-03-29

Camphor-derived compounds, method for manufacturing the same, and application thereof

#30
20110306614
2011-12-15

N-Hydroxylsulfonamide Derivatives as New Physiologically Useful Nitroxyl Donors

#31
20110281898
2011-11-17

Phenoxiacetic acid derivatives

#32
20110195945
2011-08-11

Compounds, compositions and methods for treating or preventing hypoxic or ischemic injury

#33
20110014186
2011-01-20

Arylsulfonamide-based matrix metalloprotease inhibitors

#34
20100331321
2010-12-30

Bis-(sulfonylamino) derivatives for use in therapy

#35
20100273782
2010-10-28

2,5-disubstituted arylsulfonamide CCR3 antagonists

#36
20100204213
2010-08-12

Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders

#37
20100174113
2010-07-08

Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte

#38
20100041760
2010-02-18

MONOARYL AMINOTETRALINES

#39
20100041714
2010-02-18

Bi-aryl aminotetralines

#40
20100022601
2010-01-28

Sulfonamide compounds and use thereof

#41
20090221711
2009-09-03

TRIFLUOROMETHYL-CONTAINING PHENYLSULFONAMIDE BETA AMYLOID INHIBITORS

#42
20090191193
2009-07-30

Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof

#43
20090163586
2009-06-25

Bis-(Sulfonylamino) Derivatives in Therapy 205

#44
20090091234
2009-04-09

Room temperature molten salt and display element

#45
20090023664
2009-01-22

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#46
20080214660
2008-09-04

Compounds and Methods for the Inhibition of the Expression of VCAM-1

#47
20080119555
2008-05-22

Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions

#48
20080070956
2008-03-20

Tricyclic aromatic and bis-phenyl sulfinyl derivatives

#49
20070299107
2007-12-27

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#50
20070249722
2007-10-25

Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors

#51
20070106079
2007-05-10

Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation

#52
20070099919
2007-05-03

Composition and synthesis of new reagents for inhibition of HIV replication

#53
20070078173
2007-04-05

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#54
20060293385
2006-12-28

Vitamin D receptor modulators

#55
20060293352
2006-12-28

Phenoxiacetic acid derivatives

#56
20060276493
2006-12-07

α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#57
20060189581
2006-08-24

Compounds and methods for treating transplant rejection

#58
20060030554
2006-02-09

Sulfonamides as inhibitors of histone deacetylase for the treatment of disease

#59
20050267171
2005-12-01

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#60
20050234040
2005-10-20

Tricyclic aromatic and bis-phenyl sulfinyl derivatives

#61
20050227994
2005-10-13

Decomposition inhibitor for extracellular matrix of cartilage

#62
20050171028
2005-08-04

Thioketals and thioethers for inhibiting the expression of VCAM-1

#63
20050090487
2005-04-28

Compounds and methods for the inhibition of the expression of VCAM-1

#64
20050085541
2005-04-21

Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof

#65
20050070582
2005-03-31

Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders

#66
20050026907
2005-02-03

Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease